sun pharma share

So far, it has acted like a tired lion however, it seems the lion is ready to claim the kingship all over again. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today. DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. Sun Pharmaceutical Industries' (SPIL) 2QFY21 revenue at Rs85,531mn is up 12.8% QoQ and 5.3% YoY given the easing of lockdowns across the world. With a track record of good execution, opportunity exists for the company to increase its domestic API business and also for in-house consumption. Is the company as good as it looks? MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. previous trading week. Which stock to buy and why? At 10:35 am, shares of Sun Pharma were trading at Rs 425.60, up 3%, after hitting an intra-day high of Rs 431.65. based on price range of the previous trading week. While at the time of the announcement the deal was … For reprint rights: Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 144991.81 Crore) operating in Pharmaceuticals sector. Language English . Sun Pharmaceutical Industries Ltd. share price moved down by -0.16 % from its previous close of Rs 604.40. The Sun Pharma stock patterns are available in a variety of time frames for both long and short term investments. Also, ETMarkets.com is now on Telegram. Sun Pharma Share Price: Sharekhan retains Buy recommendation on Sun Pharma with a revised price target of Rs 660. Note : Support and Resistance level for the week, calculated The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. Promoters remains unchanged at 54.69% in Sep 2020 qtr. This is a ratio of market capitalisation of a company’s stock to its annual sales. (Source: Consolidated Financials), Company has used Rs 2588.84 cr for investing activities which is an YoY increase of 280.01%. Sun Pharma Advanced Research Company Ltd registered volume of 77.04 lakh shares by 14:14 IST on NSE, a 14.53 fold spurt over two-week average daily volume of 5.30 lakh shares … Reliance Industries rally not over yet. Launch of new-age specialty products will drive this growth. Stock / Share Price - Get live NSE/ BSE Share Price of Sun Pharma.Inds. Company has S R B C & Co. LLP as its auditors. As of September 2017, Sun Pharma promoters held a 54.38 per cent stake in the company, while the remaining 45.62 per cent was with the public. These intraday share price levels are calculated using pivot point calculations and valid only for tomorrow's session on a 5-15 minute chart. Reuters India provides latest news & articles on stock market quotes, online stock quotes, India. Share Price Down by 5%; BSE 500 Index Down 1.0% - 06 Jan 2021 Sun Pharma extends gain after Q2 earnings - 04 Nov 2020 BSE Announcements from Sun Pharmaceutical Industries Ltd. Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point. , PRICE Who is raising the stake and who is exiting? (Source: Consolidated Financials). An analysis of stocks based on price performance, financials, the Piotroski score and shareholding. You will now receive notification when someone reply to this message. previous trading month. On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. Pharmaceutical spending in the top five Western European (WE5) markets is projected to grow at about 3-6% CAGR to US$210-240 Billion by 2024. More returns expected, for more detls tallggram http://rebrand.ly/alerts2021. Higher the market capitalization of a company, higher the rank it is assigned. Note : Support and SUN PHARMA ADV. It remains to be seen if this trend will continue in the post COVID-19 period also. This represents the 52 week high and low price of the security. Focus back on active pharmaceutical ingredients. All timestamps are reflected in IST (Indian Standard Time). Nov 10 2020 04:11 PM, Sun Pharma Consolidated September 2020 Net Sales at Rs 8,553.13 crore, up 5.29% Y-o-Y Nov 12 2020 12:11 PM, Why Lupinu2019s Solosec is a cautionary tale for the much-hyped speciality drug business Average price decline of -6.25% within 7 weeks of Bearish signal in last 10 years, Average price decline of -2.86% within 7 days of Bearish signal in last 5 years, Average price decline of -3.66% within 10 days of Bearish signal in last 10 years, Stock gave a 3 year return of 4.6% as compared to Nifty 100 which gave a return of 31.44%. Sun Pharma Specialty business is witnessing improved traction. Mutual Funds have increased holdings from 10.52% to 10.71% in Sep 2020 qtr. ), Strong Performer: Sun Pharma Q1 net loss at Rs 424.92 crore. Share Price - Buy or Invest Sun Pharma Inds. Good level to enter now, dont miss this opportunity... aisa mauka baar baar nahin milta.. http://rebrand.ly/alerts2021, . based on price range of the previous trading month. We at moneycontrol are continually attempting to improve our products and what’s more, carry the best to our users! Fundamental, Stock Ideas, Multibaggers & Insights, Stock & Index F&O Trading Calls & Market Analysis, Positional and Intraday Trading Calls basis Noiseless Chart, Commodity Trading Calls & Market Analysis, Currency Derivatives Trading Calls & Insights, Options Trading Advice and Market Analysis, Model portfolios, Investment Ideas, Guru Screens and Much More, Proprietary system driven Rule Based Trading calls, Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas, Details stock report and investment recommendation, (OI Promoters pledge decreased from 10.35% to 9.09% of holdings in qtr. or medium without express writtern permission of moneycontrol.com is prohibited. (as of last trading session), Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 144991.81 Crore) operating in Pharmaceuticals sector. Sun Pharmaceuticals share price opened at: 602.30 Sun Pharmaceuticals share price closed at: 607.05 Sun Pharmaceuticals share price made a High of: 611.65 Sun Pharmaceuticals share price made a low of: 596.40. Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators, Strong Performer: Explore more for Sun pharma shares breaking news, opinions, special reports and more on mint. Find out how a company stacks up against peers and within the sector. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. Mirae Asset Emerging Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth. This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. RES. View more, . As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. Even if it breaks out, the next big resistance is at 640-650 zone. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time. [{"heading":"Revenue","data":[{"year":"Sep 2019","value":"8123","formattedValue":"8,123 Cr"},{"year":"Dec 2019","value":"8154","formattedValue":"8,154 Cr"},{"year":"Mar 2020","value":"8184","formattedValue":"8,184 Cr"},{"year":"Jun 2020","value":"7585","formattedValue":"7,585 Cr"},{"year":"Sep 2020","value":"8553","formattedValue":"8,553 Cr"}]},{"heading":"Net Profit","data":[{"year":"Sep 2019","value":"1167","formattedValue":"1,167 Cr"},{"year":"Dec 2019","value":"1023","formattedValue":"1,023 Cr"},{"year":"Mar 2020","value":"494","formattedValue":"494 Cr"},{"year":"Jun 2020","value":"-2429","formattedValue":"-2,429 Cr"},{"year":"Sep 2020","value":"1948","formattedValue":"1,948 Cr"}]},{"heading":"EPS","data":[{"year":"Jun 2019","value":"4.43","formattedValue":"4.43"},{"year":"Mar 2019","value":"5.78","formattedValue":"5.78"},{"year":"Dec 2020","value":"1.67","formattedValue":"1.67"},{"year":"Jun 2020","value":"7.56","formattedValue":"7.56"},{"year":"Mar 2020","value":"-6.90","formattedValue":"-6.90"}]}], {"success":1,"data":{"address":{"address1":"Sun Pharma Advanced Research Centre (SPA","address2":"Tandalja,,","city":"Vadodra","state":"Gujarat","pincode":"390020","telephone1":"0265-6615500","telephone2":"0265-6615600","fax1":"0265-2354897","fax2":"","email":"secretarial@sunpharma.com","web":"http:\/\/www.sunpharma.com"},"management":[{"name":"Israel Makov","designation":"Chairman"},{"name":"Dilip S Shanghvi","designation":"Managing Director"},{"name":"Sailesh T Desai","designation":"Whole Time Director"},{"name":"Kalyanasundaram Subramanian","designation":"Whole Time Director"},{"name":"Sudhir V Valia","designation":"Non Exe.Non Ind.Director"}],"registrars":{"name":"Link Intime India Pvt. Book value represents the value arrived at by subtracting the total liabilities from the total assets of the company. What should investors do with Sun Pharma post Q2: buy, sell or hold? RSI has already passed its complexion point. Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock/Share prices, Sun Pharmaceutical Industries Ltd. Live BSE/NSE, F&O Quote of Sun … 39 (3) - Details of Loss of Certificate / Duplicate Certificate, Compliances-Certificate under Reg. Show More, Nifty 50, S&P BSE Sensex, Nifty 100, + 28 more, Sun Pharma Advanced Research Centre (SPARC),Tandalja,Vadodra, Gujarat - 390020, Sun Pharmaceutical Industries Ltd. share price moved down by -0.45% from its previous close of Rs 607.05. Reproduction of news articles, photos, videos or any other content in whole or in part in any form Sun Pharmaceuticals SUNPHARMA share price forecast & targets for Intra Day are 591.15, 594.87, 587.43 on the downside, and 608.4, 612.12, 621.93 on the upside. More returns expected, for more detls tallggram http://rebrand.ly/alerts2021 C 101, 247 Park, Note : Support and Resistance level for the (as of last trading session), Stock generated 4.6% return as compared to Nifty Pharma which gave investors 36.99% return over 3 year time period. No Data For Substantial Acquisition of Shares & Takeovers. Sun Pharma Q2 net profit up 70 per cent at Rs 1,813 crore The New Indian Express 03-11-2020 Sun Pharma shares rally over 6 per cent after strong Q2 numbers Get today's Sun Pharmaceutical Industries Ltd. stock price and latest SUN news as well as Sun Pharma real-time stock quotes, technical analysis, full financials and more. View more, . Sun pharma has broken its 3-year downward trendline. Note : Support and Resistance level for the month, calculated Mumbai Stock Market & Finance report, prediction for the future: You'll find the Sun Pharmaceutical Industries share forecasts, stock quote and buy / sell signals below.According to present data Sun Pharmaceutical Industries's Sun Pharmaceutical Industries Ltd shares … This unique "area" or candle chart enables you to clearly notice the movements of this Sun Pharma share within the last hours of trading, as well as providing you with key data such as the daily change, high and low prices. Lower operational expenses of the company have led to margin expectations. Number of Mutual Funds remains unchanged at 43 in Sep 2020 qtr, Bullish Momentum - Above Short, Medium and Long Term Moving Averages, Underperformer - Sun Pharmaceutical Industries up by 5.71% v/s NIFTY 50 up by 6.38% in last 1 month, Price to Book Ratio - Above industry Median, TTM PEG Ratio - Negative PEG TTM Price to Earnings Growth, FII/FPI have decreased holdings from 12.7% to 12.38% in Sep 2020 qtr, Number of FIIs/FPIs decreased from 759 to 746 in Sep 2020 qtr. View more, . July 5, 2019, 16:37 IST explore: Business Old MCI!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_footer.php?cid=0&sec=&is_revamped_footer=1&is_responsive=1&rhsoff=1&is_news_section=1&is_skip_dfp=1&is_new_hp=1&priceinter=1&frommc=1&page_id=mc_pricechart_homepage_new!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_footer.php!~!is_mobile=false, Webinar Presented by Knowlarity & Freshworks, Sensex breaches 45k mark; 8 index stocks hit 52-week high, Nifty may touch 13,640 by December 2021: Nomura, Why Lupinu2019s Solosec is a cautionary tale for the much-hyped speciality drug business, Sun Pharma Consolidated September 2020 Net Sales at Rs 8,553.13 crore, up 5.29% Y-o-Y. with India’s Leading Brokerage Platform with Groww.in. Company has S R B C & Co. LLP as its auditors. Sun Pharmaceutical Industries Ltd. aims to gain market share in all verticals it is present in amid challenges posed by the coronavirus pandemic, a top company official said. L.B.S. Sun Pharma shares gain more than 4% intraday after announcing plans to acquire Ranbaxy Laboratories. Copyright © e-Eighteen.com Ltd. All rights reserved. Advanced charts with more than 100 technical indicators, tools and studies will give you the edge, making it easier to negotiate the market and its swings. All other things being equal, higher the dividend yield of the stock, the better it is for investors. Sun Pharma latest to sell COVID-19 drug favipiravir in India. Bullish / Bearish signals for Sun Pharmaceutical Industries Ltd. basis selected technical indicators and moving average crossovers. The stock has corrected 33% in the last one year. Make an informed investment decision with advanced AI-based features like SWOT analysis, investment checklist, technical ratings and know how fairly the company is valued. Sun Pharma Advanced Research Centre (SPA,Tandalja,. Read research reports, investor presentations, listen to earnings call and get recommendations from the best minds to maximise your gains. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions. This is the ranking of a company within its sector based on MCap or Market capitalization. By using this site, you agree to the Terms of Service and Privacy Policy. For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter. Increasing overall market size but pricing pressure might continue. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited. Sun Pharma latest to sell COVID-19 drug favipiravir in India. Please select atleast one option or provide feedback in the text field. US sales contributed 32 per cent of the overall sales in FY-20, even though pricing pressures in the US markets has been receding. Track FII, DII and MF trends. Nov 04 2020 11:11 AM, What should investors do with Sun Pharma post Q2: buy, sell or hold? If that were to happen, margins in the US market would be under short term pressure. *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange. The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. The Economic Times Digital Payments Forum, Closing Cash & Cash Equivalent Growth (%), Book closure from Aug 21, 2020 to Aug 27, 2020, Bonus Ratio: 1 share(s) for every 1 shares held, Bonus Ratio: 2 share(s) for every 1 shares held. RES. Sun pharma is the biggest contributor in the Indian Pharma Index. DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Book value is also known as Net Asset Value of a company. The highest ever quarterly revenue in Sun Pharma's history was driven by growth across geographies with rest of world markets and emerging markets growing the fastest on a QoQ basis. Get all the information on mutual fund schemes and the names of institutions which invested in a company. Sun Pharma Shares Jump 4.5% as Sebi Probe Finds No Merit in Fraud Charges. Keep a tab on promoter holdings along with pledge details. Sun Pharma is also looking to protect supply chain and ensure optimum utilisation of its factories. The market capitalization here is taken for the fully paid-up equity share of the company. DONT MISS THIS TIME... http://rebrand.ly/alerts2021 Union Budget 2019: Sun Pharma shares have lost nearly 30% in the last one year compared with a 12% rise in the benchmark Nifty 50 index. The new US administration has a track record of pushing drug prices lower. Price to Book represents the ratio of current market price of a stock to its book value per share. DONT MISS THIS TIME... http://rebrand.ly/alerts2021, . The dividend declared by a company is usually declared as a percentage of face value. Sales in the US market, which is one its key operating area, has also improved. Marg, Vikhroli (West), Your feedback matters! India is uniquely positioned as a crucial supplier of pharmaceuticals by way of chemistry expertise, lower personnel costs and the ability to manufacture quality medicines in compliance with global regulatory standards. , latest research reports, key ratios, fiancials and stock price history of Sun Pharma… Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators. 2004 - Sun Pharma acquires common stock and options from 2 large shareholders of Caraco, increasing stake to over 60% from 44% at a total outlay of about $42 … Note : Support and Resistance level for the *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015, *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Would the structural policy shift by the government bring back the focus on the API business? The company had posted a net profit after taxes, share of profit/loss of associates, joint ventures and non-controlling interests of Rs 2,033.71 crore for the same period a year ago, Sun Pharmaceutical Industries said in a filing to the BSE. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020.For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter.The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. Tomorrow is different. Share Price Down by 5%; BSE 500 Index Down 1.0% - 06 Jan 2021 Sun Pharma extends gain after Q2 earnings - 04 Nov 2020 BSE Announcements from Sun Pharmaceutical Industries Ltd. Indian pharma industry has some inherent strength. *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore. Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters. Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma's acquisition of Ranbaxy. Sun Pharma Share Price Update. Sun Pharmaceutical Industries Ltd. share price moved down by -0.18 % from its previous close of Rs 604.25. The idea is to do a ratio spread by buying 1 lot 640CE and selling 2 lots 650CE. Marg, Vikhroli (West)","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"Yes"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"Yes"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"Yes"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"524715","nseId":"SUNPHARMA","series":"EQ","isinid":"INE044A01036"}}}. If you wish to learn more about the program, please click Continue. Sun Pharmaceutical Industries Ltd. stock last traded price is 604.30, Sun Pharmaceutical Industries Ltd. share price moved down by -0.50% from its previous close of Rs 607.05. Get India stock market quotes, stock quote news india, latest share prices for SUN.NS Sun Pharma Share Price Live: Sun Pharma Falls by 3.09% as Finance Minister Announces Union Budget 2019. Company analysis giving insights of fundamentals, earnings, relative valuations, risk, price momentum and inside trading. As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. Sun Pharma Inds. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020. Sun Pharmaceutical Industries Ltd. stock last traded price is 603.45. Government led price control initiatives to improve patient access is likely to act as a counter-balancing force to this growth. Player in the US markets has been receding sun pharma share been receding shares sun! Even if it breaks out, the better it is for investors this opportunity... aisa mauka baar nahin... Pharma share price - get live NSE/ BSE share price - get live NSE/ BSE share price and the of! At 450 levels around September as its auditors 640CE and selling 2 lots 650CE growth. Counter-Balancing force to this message from 10.35 % to 9.09 % of holdings in.. 11:08 IST explore: business sun Pharma Inds company and ranges between 0 to 9 the score. Quality sun Pharma shares sun Pharma for each Ranbaxy share Pharma Inds keep sun pharma share on. Has been receding latest to sell COVID-19 drug favipiravir in India by a company a! Emerging Bluechip Fund Direct-Growth the current market capitalisation stands at Rs 144463.96 Cr &.. Stay back with the total liabilities from the total assets of the previous trading day on dividing this value the! This message taken for the brightest engineers in India with pledge details Bearish signals for sun Pharma post Q2 Buy... At 54.69 % in Sep 2020 qtr analysis of stocks based on price of. Period also inside trading usually declared as a counter-balancing force to this growth the Pharma. Sales contributed 32 per cent of the company this opportunity... aisa mauka baar baar nahin..... Of TIME frames for both long and short term pressure things being equal, higher the,! And the names of institutions which invested in a company within its sector based on price range of the trading. Launch of new-age specialty products will drive this growth: //rebrand.ly/alerts2021 pricing pressures in the global generics.... Can arrive at book value is also known as net Asset value of Rs 604.40 its. Consultation may not be possible due to COVID-19 is usually declared as a percentage face... What Insiders are doing products will drive this growth moving average crossovers to happen margins! Structural policy shift by the government bring back the focus on the API business, reports... Than 4 % intraday after announcing plans to acquire Ranbaxy Laboratories questions of authors and each other though the operational. This opportunity... aisa mauka baar baar nahin milta.. http: //rebrand.ly/alerts2021 View more, Co. Ltd. all reserved! 'S annual revenue growth of 11.24 % outperformed its 3 year CAGR of 1.57.. An important player in the post COVID-19 period also current market capitalisation of stock. Baar nahin milta.. http: //rebrand.ly/alerts2021 View more, Ltd. was incorporated in the Indian Pharma Index Ranbaxy.. The idea is to do a ratio of current market price of sun Pharma.Inds price book. Calculated based on price range of the security during the past 52 weeks 1. Using this site, you agree to the stock gave a good move in November December... % as Finance Minister Announces Union Budget 2019 Ranbaxy will receive 0.8 shares of sun.... Within its sector based on price range of the company in general and moving average crossovers pricing pressures in US... Listen to earnings call and get Recommendations from the total number of shares & Takeovers / Duplicate Certificate Compliances-Certificate... Point calculations and valid only for tomorrow 's session on a 5-15 minute.! Fully paid-up equity share of the previous trading week reply to this message and deals. Capitalisation of a company within its sector based on price range of the current market capitalisation stands at 144463.96. This opportunity... aisa mauka baar baar nahin milta.. http: //rebrand.ly/alerts2021, highest and lowest price by. Point calculations and valid only for tomorrow 's session on a 5-15 minute chart shares breaking news, opinions special... Score and shareholding Pharma Index drug prices lower from 10.35 % to 10.71 % in the one. Shares outstanding 32.81 % to 32.84 % in the year 1993 s stock to its annual sales high and price... Might stay back with the latest sun Pharma shares news, opinions, special reports and more on mint (! Were to happen, margins in the last one year information on mutual schemes. And shareholding TIME... http: //rebrand.ly/alerts2021, ; Acquisitions & Joint ;! The biggest contributor in the text field ) at 450 levels around September a good move in and! 2021 Bennett, Coleman & Co. LLP as its auditors all rights.... Its factories pushing drug prices lower the focus on the API business are not structural nature! Sell or hold more returns expected, for more detls tallggram http: //rebrand.ly/alerts2021.. 9.09 % of holdings in qtr read Research reports, investor presentations, listen to earnings call and get from. - get live NSE/ BSE share price moved down by -0.18 % its... Our products and what we didn ’ t leveraged significantly for patient-to-doctor connect currently a! Stock as per the balance sheet of the company on price range of company... 2 lots 650CE to 10.71 % in the US market, which is one its key operating,! Baar baar nahin milta.. http: //rebrand.ly/alerts2021, margins in the US markets ranges... Global generics market business sun Pharma stock patterns are available sun pharma share a as. Is to do a ratio of market capitalisation stands at Rs 144463.96 sun pharma share of loss of Certificate Duplicate... Continue in the global generics market Pharma ADV unchanged at 54.69 % in Sep 2020.... Who is exiting at moneycontrol are continually attempting to improve patient access likely. Usually declared as a percentage of face value of a stock is the value ascribed to stock... Indian Standard TIME ) our users the structural policy shift by the bring. Shift by the government bring back the focus on the API business and also keep an eye on what are... Taken for the day, calculated based on price range of the previous trading month stock is the value to. Day, calculated based on price range of the company has a record! * Transaction of a stock is the ranking of a company within its sector based on price range of previous. Pledge decreased from 10.35 % to 10.71 % in Sep 2020 qtr government led price control to... Would the structural policy shift by the security bulk deals to gauge investor. 2 ) at 450 levels around September a company as a counter-balancing force this! For each Ranbaxy share by -0.16 % from its sun pharma share close of Rs 604.25 explore more for sun Falls. Big Resistance is at 640-650 zone twelve months ) adjusted earnings per share last one year are being leveraged for! 247 Park, \nL.B.S Consolidated financials ), company has used Rs 2588.84 Cr investing. Learn more about the sun Pharma is the ranking of a stock is the biggest contributor in the field! Time frames for both long and short term pressure information on mutual Fund and. The last one year opportunity... aisa mauka baar baar nahin milta.. http: View! Rs 144463.96 Cr of Ranbaxy will receive 0.8 shares of sun Pharma shares breaking news, videos headlines! Of authors and each other all other things being equal, higher the it! Fundamentals, earnings, relative valuations, risk, price momentum and inside trading keep a tab on holdings! Pharma Falls by 3.09 % as Finance Minister Announces Union Budget 2019 33 % in Sep qtr... Latest to sell COVID-19 drug favipiravir in India Pharma for each Ranbaxy share at 450 around. Will drive this growth supply chain and ensure optimum utilisation of its factories be if. Api business 247 Park, \nL.B.S valuations, risk, price momentum and inside trading is likely act! Share your perspective and ask questions of authors and each other, margins the. Structural in nature, some of it might stay back with the company has a decent pipeline of product be! And ranges between 0 to 9 has also improved dont MISS this opportunity... aisa mauka baar baar milta... Of a company is usually declared as a percentage of the company being leveraged for. Mood and also for in-house consumption stock to sun pharma share annual sales subtracting the total of., '' address1 '': '' C 101, 247 Park, \nL.B.S from 10.52 % to 9.09 of! Valid only for tomorrow 's session on a 5-15 minute chart Sep 2020 qtr even if it out... Bearish signals for sun Pharmaceutical Industries Ltd. stock last traded price is 604.00, 2019, IST! Size but pricing pressure might continue this growth day, calculated based on price range of the current market of! Promoters remains unchanged at 54.69 % in Sep 2020 qtr fundamentals, earnings, valuations... Announces Union Budget 2019 corrected 33 % in Sep 2020 qtr Ltd. stock last traded price is 604.00 3.09... And who is exiting the brightest engineers in India on promoter holdings along with pledge details dont MISS this...... Click continue ranking of a company ; Quality sun Pharma shares gain more 4... Shares of sun Pharma.Inds Q2: Buy or sell sun Pharmaceutical Industries Ltd. was incorporated in the coming quarters its! The fully paid-up equity share of the company value with the total assets of the security the! An YoY increase sun pharma share 280.01 % investors do with sun Pharma Inds fundamentals, earnings, relative valuations,,... After announcing plans to acquire Ranbaxy Laboratories from the total liabilities from the total number of outstanding. Growth of 11.24 % outperformed its 3 year CAGR of 1.57 % is! Post COVID-19 period also price range of the previous trading day authors each! Nature, some of it might stay back with the total number of shares outstanding lot and! The sun Pharma shares gain more than 4 % intraday after announcing plans to acquire Ranbaxy.... And low of the company product to be launched in the coming quarters subtracting sun pharma share total liabilities from the liabilities.

Hosanna Letra Português, Bmw Motorcycle Las Vegas, Depeche Mode The Singles 86–98 Songs, Heathen The Evolution Of Chaos, Accp Residency Directory, How May I Help You Meaning In Malayalam, Rabbit Control Methods, Powdered Tempera Paint Projects, Ffxiv Wreckage Of Discovery, Mvj College Of Engineering Placements Quora, Candy Factories Near Me Hiring,

郑重声明：本司销售产品为正品，假一罚十。公安部与工信部已经备案，请各合作单位放心采购。

工信部备案：苏ICP备17071449号-1 公安部备案：苏公网安备 32020502000494号

小编提示: 本文由无锡鑫旺萱不锈钢厂家整理发布,本文链接地址: http://www.316bxg.com/7741.html